Ann: Patrys Investor Presentation - September 2014, page-7

Free speech is different to accusing someone of working for a company and having a hidden agenda.
Anyway lets stay on topic.


I have been pretty disappointed with the communication from management and performance of the stock.
If we can hit these milestones by the end of this year as stated than we should see the share price steadily increasing again.



Key Milestone Projected Timing
(CY)
PAT-SM6:
o Final data from monotherapy MM trial
o Complete GMP manufacturing for combination MM trial
o Commence combination Phase Ib/IIa MM trial
o Preclinical and clinical data published
1Q, 2014
2H, 2014
4Q, 2014
4Q, 2014

PAT-LM1:
o Complete manufacturing process development ready for scale-up
o Preclinical data published
2H, 2014
2H, 2014
PAT-SC1:
o Preclinical & clinical trial (gastric cancer) data published
o Out-licensing deal
1Q, 2014
2014

Discovery Abs:
o Target work on PAT-SM3, PAT-SM4, PAT-H12 2014